These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 28535419)
1. Comparison of the efficacy of fixed-dose enoxaparin and adjusted-dose unfractionated heparin in patients with cerebral venous thrombosis. Korathanakhun P; Petpichetchian C; Petpichetchian W; Sathirapanya P Clin Neurol Neurosurg; 2017 Aug; 159():50-54. PubMed ID: 28535419 [TBL] [Abstract][Full Text] [Related]
2. Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis. Lurkin A; Derex L; Fambrini A; Bertoletti L; Epinat M; Mismetti P; Dargaud Y Cerebrovasc Dis; 2019; 48(1-2):32-37. PubMed ID: 31480062 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group. Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025 [TBL] [Abstract][Full Text] [Related]
4. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis. Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F; Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210 [TBL] [Abstract][Full Text] [Related]
5. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators. Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256 [TBL] [Abstract][Full Text] [Related]
6. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred? Weiss A; Brose S; Ploetze K; Matschke K Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452 [TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial for efficacy of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in thrombo-prophylaxis. Ishi SV; Lakshmi M; Kakde ST; Sabnis KC; Jagannati M; Girish TS; Jeyaseelan L; Cherian AM J Assoc Physicians India; 2013 Dec; 61(12):882-6. PubMed ID: 24968543 [TBL] [Abstract][Full Text] [Related]
8. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Coutinho JM; Ferro JM; Canhão P; Barinagarrementeria F; Bousser MG; Stam J; Stroke; 2010 Nov; 41(11):2575-80. PubMed ID: 20930161 [TBL] [Abstract][Full Text] [Related]
9. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients. Arnold JD; Dart BW; Barker DE; Maxwell RA; Burkholder HC; Mejia VA; Smith PW; Longley JM Am Surg; 2010 Jun; 76(6):563-70. PubMed ID: 20583509 [TBL] [Abstract][Full Text] [Related]
10. Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis. Riess H; Koppenhagen K; Tolle A; Kemkes-Matthes B; Gräve M; Patek F; Drexler M; Siemens HJ; Harenberg J; Weidinger G; Brom J; Haas S; Thromb Haemost; 2003 Aug; 90(2):252-9. PubMed ID: 12888872 [TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. De A; Roy P; Garg VK; Pandey NK Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176 [TBL] [Abstract][Full Text] [Related]
12. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry. Auffret V; Leurent G; Boulmier D; Bedossa M; Zabalawi A; Hacot JP; Coudert I; Filippi E; Castellant P; Rialan A; Rouault G; Druelles P; Boulanger B; Treuil J; Avez B; Le Guellec M; Gilard M; Le Breton H Arch Cardiovasc Dis; 2016 Dec; 109(12):696-707. PubMed ID: 27818120 [TBL] [Abstract][Full Text] [Related]
14. Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis. Chong BH; Brighton TA; Baker RI; Thurlow P; Lee CH; J Thromb Thrombolysis; 2005 Jun; 19(3):173-81. PubMed ID: 16082604 [TBL] [Abstract][Full Text] [Related]
15. Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and literature review. Alet M; Ciardi C; Alemán A; Bandeo L; Bonardo P; Cea C; Cirio J; Cossio J; Cuculic M; Esnaola MM; García-Pérez F; Giner F; Gómez-Schneider M; Isaac C; Lepera S; Martínez C; Martínez-Lorenzín R; Montes M; Orzuza G; Persi G; Povedano G; Pujol-Lereis V; Quiroga-Narváez J; Romano M; Sabio R; Viglione J; Zurrú MC; Saposnik G; J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105145. PubMed ID: 32912503 [TBL] [Abstract][Full Text] [Related]
16. Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial. Pineo G; Lin J; Stern L; Subrahmanian T; Annemans L J Hosp Med; 2012 Mar; 7(3):176-82. PubMed ID: 22058011 [TBL] [Abstract][Full Text] [Related]
17. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin. Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL; Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125 [TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group. Bergmann JF; Neuhart E Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991 [TBL] [Abstract][Full Text] [Related]
19. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Yaghi S; Shu L; Bakradze E; Salehi Omran S; Giles JA; Amar JY; Henninger N; Elnazeir M; Liberman AL; Moncrieffe K; Lu J; Sharma R; Cheng Y; Zubair AS; Simpkins AN; Li GT; Kung JC; Perez D; Heldner M; Scutelnic A; Seiffge D; Siepen B; Rothstein A; Khazaal O; Do D; Kasab SA; Rahman LA; Mistry EA; Kerrigan D; Lafever H; Nguyen TN; Klein P; Aparicio H; Frontera J; Kuohn L; Agarwal S; Stretz C; Kala N; El Jamal S; Chang A; Cutting S; Xiao H; de Havenon A; Muddasani V; Wu T; Wilson D; Nouh A; Asad SD; Qureshi A; Moore J; Khatri P; Aziz Y; Casteigne B; Khan M; Cheng Y; Mac Grory B; Weiss M; Ryan D; Vedovati MC; Paciaroni M; Siegler JE; Kamen S; Yu S; Leon Guerrero CR; Atallah E; De Marchis GM; Brehm A; Dittrich T; Psychogios M; Alvarado-Dyer R; Kass-Hout T; Prabhakaran S; Honda T; Liebeskind DS; Furie K Stroke; 2022 Mar; 53(3):728-738. PubMed ID: 35143325 [TBL] [Abstract][Full Text] [Related]
20. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Hillbom M; Erilä T; Sotaniemi K; Tatlisumak T; Sarna S; Kaste M Acta Neurol Scand; 2002 Aug; 106(2):84-92. PubMed ID: 12100367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]